Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hanifin, 1980, Diagnostic features of atopic dermatitis, Acta Dermatovener (Stockholm), 60, 44
Eichenfield, 2014, Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis, J Am Acad Dermatol, 70, 338, 10.1016/j.jaad.2013.10.010
Silverberg, 2013, Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study, J Allergy Clin Immunol, 132, 1132, 10.1016/j.jaci.2013.08.031
Silverberg, 2016, Addressing treatment challenges in atopic dermatitis with novel topical therapies, J Dermatolog Treat, 27, 568, 10.1080/09546634.2016.1174765
Berth-Jones, 1997, Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis, Br J Dermatol, 136, 76, 10.1111/j.1365-2133.1997.tb08750.x
Zonneveld, 1996, The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens, Br J Dermatol, 135, 15, 10.1111/j.1365-2133.1996.tb00704.x
Kim, 2016, Importance of concomitant topical therapy in moderate-to-severe atopic dermatitis treated with cyclosporine, Dermatol Ther, 29, 120, 10.1111/dth.12333
van der Schaft, 2015, Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis, Br J Dermatol, 172, 1621, 10.1111/bjd.13730
van der Schaft, 2016, Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis, Br J Dermatol, 175, 199, 10.1111/bjd.14398
Haeck, 2011, Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial, J Am Acad Dermatol, 64, 1074, 10.1016/j.jaad.2010.04.027
Granlund, 2001, Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis, Acta Derm Venereol, 81, 22, 10.1080/000155501750208137
Politiek, 2016, Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis, Br J Dermatol, 174, 201, 10.1111/bjd.13961
Ring, 2012, Guidelines for treatment of atopic eczema (atopic dermatitis) part I, J Eur Acad Dermatol Venereol, 26, 1045, 10.1111/j.1468-3083.2012.04635.x
Ring, 2012, Guidelines for treatment of atopic eczema (atopic dermatitis) part II, J Eur Acad Dermatol Venereol, 26, 1176, 10.1111/j.1468-3083.2012.04636.x
Sidbury, 2014, Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents, J Am Acad Dermatol, 71, 327, 10.1016/j.jaad.2014.03.030
Sidbury, 2014, Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches, J Am Acad Dermatol, 71, 1218, 10.1016/j.jaad.2014.08.038
Eichenfield, 2014, Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies, J Am Acad Dermatol, 71, 116, 10.1016/j.jaad.2014.03.023
Katayama, 2016, Japanese guidelines for atopic dermatitis 2016, Allergol Int
Garritsen, 2014, Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research, Br J Dermatol, 170, 501, 10.1111/bjd.12645
Gandhi, 2015, Targeting key proximal drivers in type 2 inflammation in disease, Nature Rev Drug Disc, 15, 35, 10.1038/nrd4624
Wenzel, 2016, Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta-agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging study, Lancet, 388, 31, 10.1016/S0140-6736(16)30307-5
Bachert, 2016, Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomised clinical trial, JAMA, 315, 469, 10.1001/jama.2015.19330
Beck, 2014, Dupilumab treatment in adults with moderate-to-severe atopic dermatitis, N Engl J Med, 371, 130, 10.1056/NEJMoa1314768
Thaçi, 2016, Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial, Lancet, 387, 40, 10.1016/S0140-6736(15)00388-8
Simpson, 2016, Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): a phase IIb, randomised, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD), J Am Acad Dermatol, 75, 506, 10.1016/j.jaad.2016.04.054
Simpson, 2016, Two phase 3 trials of dupilumab versus placebo in atopic dermatitis, N Engl J Med, 375, 2335, 10.1056/NEJMoa1610020
Jacob, 2006, Corticosteroid classes: a quick reference guide including patch test substances and cross-reactivity, J Amer Acad Dermatol, 54, 723, 10.1016/j.jaad.2005.12.028
Simpson E, Beck L, Gadkari A, et al. Defining a responder on the peak pruritus numerical rating scale (NRS) in patients with moderate-to-severe atopic dermatitis: detailed analysis from randomized trials of dupilumab. American Academy of Dermatology, 75th Annual Meeting, March 3–7, 2017; Orlando, FL, USA: Abstr 4789.
Schram, 2012, EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference, Allergy, 67, 99, 10.1111/j.1398-9995.2011.02719.x
Basra, 2015, Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data, Dermatology, 230, 27, 10.1159/000365390
Bjelland, 2002, The validity of the Hospital Anxiety and Depression Scale. An updated literature review, J Psychosom Res, 52, 69, 10.1016/S0022-3999(01)00296-3
Simpson, 2016, Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults, J Am Acad Dermatol, 74, 491, 10.1016/j.jaad.2015.10.043
Sanchez-Perez, 2013, Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: the PSEDA study, Actas Dermosifiliogr, 104, 44
Von Kobyletzki, 2017, What factors are important to patients when assessing treatment response: an international cross-sectional survey, Acta Derm Venereol, 96, 86, 10.2340/00015555-2480
Silverberg, 2015, Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study, J Invest Dermatol, 135, 56, 10.1038/jid.2014.325
Yaghmaie, 2013, Mental health comorbidity in atopic dermatitis, J Allergy Clin Immunol, 131, 428, 10.1016/j.jaci.2012.10.041
Wenzel, 2013, Dupilumab in persistent asthma with elevated eosinophil levels, N Engl J Med, 368, 2455, 10.1056/NEJMoa1304048
Velsen van, 2010, Percutaneous absorption of potent topical corticosteroids in patients with severe atopic dermatitis, J Am Acad Dermatol, 63, 911, 10.1016/j.jaad.2009.12.048
Decani, 2014, Iatrogenic Cushing's syndrome and topical steroid therapy: case series and review of the literature, J Dermatol Treatment, 25, 495, 10.3109/09546634.2012.755252